These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27322347)

  • 41. Vagus nerve stimulation.
    Lulic D; Ahmadian A; Baaj AA; Benbadis SR; Vale FL
    Neurosurg Focus; 2009 Sep; 27(3):E5. PubMed ID: 19722820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurostimulation. A promising therapeutic option for medically refractory epilepsy.
    Hassan A; Al-Quliti KW
    Neurosciences (Riyadh); 2014 Jan; 19(1):4-10. PubMed ID: 24419442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive long-term outcome of best drug treatment with or without add-on vagus nerve stimulation for epilepsy: a retrospective matched pairs case-control study.
    Hoppe C; Wagner L; Hoffmann JM; von Lehe M; Elger CE
    Seizure; 2013 Mar; 22(2):109-15. PubMed ID: 23206433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
    Thibert RL; Conant KD; Braun EK; Bruno P; Said RR; Nespeca MP; Thiele EA
    Epilepsia; 2009 Nov; 50(11):2369-76. PubMed ID: 19453717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of epilepsy in mentally retarded children using the newer antiepileptic drugs, vagus nerve stimulation, and surgery.
    Shields WD
    J Child Neurol; 2004 Aug; 19 Suppl 1():S58-64. PubMed ID: 15526971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation.
    Rong P; Liu A; Zhang J; Wang Y; Yang A; Li L; Ben H; Li L; Liu R; He W; Liu H; Huang F; Li X; Wu P; Zhu B
    Chin Med J (Engl); 2014; 127(2):300-4. PubMed ID: 24438620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deep brain stimulation for medically refractory epilepsy.
    Ellis TL; Stevens A
    Neurosurg Focus; 2008 Sep; 25(3):E11. PubMed ID: 18759612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV).
    Bialer M; Johannessen SI; Koepp MJ; Levy RH; Perucca E; Tomson T; White HS
    Epilepsy Res; 2019 Jul; 153():66-67. PubMed ID: 30910314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Refractory epilepsy.
    Banerjee TK; Das SK
    J Assoc Physicians India; 2013 Aug; 61(8 Suppl):52-4. PubMed ID: 24818331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of epilepsy in drug-resistant patients.
    Smith BJ; Cole AJ
    CNS Spectr; 2010 Jan; 15(1 Suppl 2):1, 3-7; quiz 7-8. PubMed ID: 20394187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies.
    Valentín A; García Navarrete E; Chelvarajah R; Torres C; Navas M; Vico L; Torres N; Pastor J; Selway R; Sola RG; Alarcon G
    Epilepsia; 2013 Oct; 54(10):1823-33. PubMed ID: 24032641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in sleep patterns after vagus nerve stimulation, deep brain stimulation or epilepsy surgery: Systematic review of the literature.
    Romero-Osorio Ó; Gil-Tamayo S; Nariño D; Rosselli D
    Seizure; 2018 Mar; 56():4-8. PubMed ID: 29414594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
    Wilmshurst JM; Gaillard WD; Vinayan KP; Tsuchida TN; Plouin P; Van Bogaert P; Carrizosa J; Elia M; Craiu D; Jovic NJ; Nordli D; Hirtz D; Wong V; Glauser T; Mizrahi EM; Cross JH
    Epilepsia; 2015 Aug; 56(8):1185-97. PubMed ID: 26122601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-resective surgery and radiosurgery for treatment of drug-resistant epilepsy.
    Romanelli P; Striano P; Barbarisi M; Coppola G; Anschel DJ
    Epilepsy Res; 2012 May; 99(3):193-201. PubMed ID: 22245137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.
    Pati S; Alexopoulos AV
    Cleve Clin J Med; 2010 Jul; 77(7):457-67. PubMed ID: 20601619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Headache Perception in an Epilepsy Patient with Neuromodulation by Anterior Thalamic Nuclei Deep Brain Stimulation: A Case Report.
    Pintea B; Surges R; Boström J
    J Neurol Surg A Cent Eur Neurosurg; 2020 Jul; 81(4):368-371. PubMed ID: 32176923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature.
    Connor DE; Nixon M; Nanda A; Guthikonda B
    Neurosurg Focus; 2012 Mar; 32(3):E12. PubMed ID: 22380853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vagus nerve stimulation in the treatment of patients with pharmacoresistant epilepsy: our experiences.
    Hajnsek S; Petelin Z; Poljaković Z; Mrak G; Paladino J; Desnica A
    Coll Antropol; 2011 Sep; 35(3):755-60. PubMed ID: 22053552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Vagus nerve stimulation for the treatment of refractory epilepsy. State of the art].
    García-March G; Sánchez-Ledesma MJ; Broseta J
    Neurocirugia (Astur); 2008 Oct; 19(5):416-26. PubMed ID: 18936858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.